Institut Francais De Recherche Pour L'exploitation De La Mer (ifremer)

Other

Assistance Publique-hopitaux De Paris

Centre National De La Recherche Scientifique

Université René Descartes Paris 5

Institut Francis De Recherche Pour L'exploitation De La Recherche

Institut Francais De Recherche Pour L'exploitation De La Mer

Patrick Durand

Jacqueline Jozefonvicz

Sylvia Colliec-Jouault

Corinne Sinquin

Didier Letourneur

Karim Senni

Anne-Marie Fischer

Marvin Edeas

Albert Lindenbaum

Annie Landrein

Philippe Roy

Jean Millet

Jack Legrand

Alain Foucault

Gaston-Jacques Godeau

Roland De La Poype

Frederic Chaubet

Catherine Boisson-Vidal

Catherine Vidal

Fran&ccedil;ois De La Poype

Sylvia Colliec

Jacqueline Bretaudiere

Bernard Kloareg

Sylvie Igondjo-Tchen Changotade

Sylvia Colliec Jouault

Alain Nardella

Jean-Michel Rosant

G&eacute;rard Patissier

Alexandrine Foucault-Bertaud

Catherine Blondin

Bruno Gogly

Bernard Pellat

Grégory Korb

Maya Brigitte Baroukh

Jean-Louis Saffar

Gregory Korb

The present invention relates to the use of fucans with a weight-average molar mass of between 5000 and 100 000 g/mol, for the purposes of bone grafting, engineering and regeneration.

Bone substitute comprising fucans and methods of making and use thereof

The invention concerns the use of an oyster enzymatic hydrolysate of oyster flash hydrolyzed by a protease as a cosmetic composition.

Cosmetic composition containing oyster flash enzymatic hydrolysates

The invention concerns the use of an oyster enzymatic hydrolysate for preparing a composition eliminating free radicals. The invention is characterized in that said hydrolysate is obtainable by hydrolysis of oyster flesh by a protease. The invention is applicable in therapy, dietetics and cosmetology.

Use of oyster flesh enzymatic hydrolysates for preparing compositions eliminating free radicals

The invention concerns the use of a sulphated polysaccharide capable of being obtained by radical depolymerization of a raw fucan derived from Pheophyceae, said polysaccharide having a molar mass not more than 10,000 g/mol, to obtain a medicine for preventing or treating vascular thrombosis, in particular venous thrombosis, arterial thrombosis and arterial restenosis.

Low molecular weight sulphated polysaccharide to obtain a medicine with antithrombotic activity

The invention concerns the use of fucanes for obtaining medicines for modulating metalloprotease and inhibiting leukocytic elastase. Said medicines help activate collagen synthesis inhibit proliferation of gingival fibroblasts, and activate proliferation of dermal fibroblasts. They are useful in particular for treating periodontal pathologies and dermal lesions.

Use of fucane for regulating the reconstruction of connective tissue

A centrifuge partition chromatography device for separating a liquid into at least two phases, comprising at least one flat ring ( ) that can be rotationally driven around its axis, disposed in a substantially vertical position. Said ring ( ) comprises a plurality of cells ( ) whose dimensions are greater in a first direction than the dimensions in a second direction which is substantially perpendicular to the first, disposed side by side and distributed along the periphery of said ring ( ) in addition to being connected to each other in a series by inlet and outlet ducts ( ) terminating in the opposite respective ends of each cells ( ) enabling the circulation of liquid. The invention is characterized in that said ducts ( ) are disposed in such a way that the liquid supply jet penetrates the cells ( ) in a direction that includes at least one radial component relative to the axis of rotation of said ring ( ).

Cell centrifuge partition chromatography device

Method for obtaining sulphated polysaccharides

Sulphated polysaccharides, anticoagulant agent and anticomplementary

Growing community of inventors

Reze, France

Patrick Durand